Patents by Inventor Claus Tobias Lattemann

Claus Tobias Lattemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220136029
    Abstract: The present invention concerns a genetically modified bacterium and to its industrial application, in particular in the 1,2-dehydrogenation of steroids.
    Type: Application
    Filed: February 7, 2020
    Publication date: May 5, 2022
    Inventors: Claus Tobias LATTEMANN, Bernd JANOCHA, Hans-Falk RASSER, Sebastian RISSOM
  • Publication number: 20220064692
    Abstract: The present invention relates to a method for producing a recombinant polypeptide of interest in a microbial host cell, comprising (a) introducing a polynucleotide encoding the polypeptide of interest into a microbial host cell which has been modified such that an enzymatic activity selected from the group consisting of ketol-acid reductoisomerase (NADP(+)) activity (EC 1.1.1.86), acetohydroxyacid synthase activity (EC 2.2.1.6), aspartate kinase activity (EC 2.7.2.4), homoserine dehydrogenase activity (EC 1.1.1.3), and L-threonine dehydratase activity (EC 4.3.1.19) is modulated in said microbial host cell as compared to the enzymatic activity in an unmodified microbial host cell, and (b) expressing said polypeptide of interest in said microbial host cell. Moreover, the present invention relates to a method for reducing misincorporation of at least one non-canonical branched-chain amino acid into a recombinant polypeptide of interest expressed in a microbial host cell.
    Type: Application
    Filed: December 10, 2019
    Publication date: March 3, 2022
    Inventors: Peter HAUPTMANN, Angel CORCOLES GARCIA, Claus Tobias LATTEMANN, Arne MATZEN, Peter NEUBAUER
  • Publication number: 20020161192
    Abstract: The present invention relates to novel recombinant live vaccines, which provide protective immunity against an infection by Helicobacter pylori and a method of screening H. pylori antigens for optimized vaccines.
    Type: Application
    Filed: October 15, 2001
    Publication date: October 31, 2002
    Inventors: Thomas F. Meyer, Rainer Haas, Yan Zhengxin, Oscar Gomez-Duarte, Bernadette Lucas, Jochen Maurer, Carol Patrice Gibbs, Claus Tobias Lattemann